On behalf of Dr. Francois Bénard, Vice President Research, and Dr. Pamela Hoodless, Director, Terry Fox Laboratory, please join us in welcoming Dr. Kevin Hay, a newly appointed Clinician-Scientist, to the Terry Fox Laboratory and the Leukemia/Bone Marrow Transplant Program of BC.
Kevin received his Master of Science in Immunology at the University of Manitoba (2008), followed by an MD (2011). After completing his residency in Internal Medicine (2014) and a clinical fellowship in Haematology (2016) at the University of British Columbia, he was awarded a scholarship through the Clinician Investigator Program of UBC to pursue a postdoctoral fellowship in cellular immunotherapy which he completed at the Fred Hutchinson Cancer Research Center in Seattle, Washington under the mentorship of Dr. Cameron Turtle. Dr. Hay’s translational research focuses on development and clinical application of novel cellular immunotherapies, particularly chimeric antigen receptor-modified (CAR-)T cells.
